# Design Therapeutics, Inc.: Form DEF 14A, filed Apr 13, 2023

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: DEF 14A
- Filed: 2023-04-13
- Accepted by EDGAR: Apr 13, 2023, 16:36 ET
- Period: 2023-05-31
- Accession: 0000950170-23-012723
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000095017023012723/dsgn-def14a-2023.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000095017023012723/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000095017023012723/dsgn-def14a-2023.htm

Filed Apr 13, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-012723. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.